{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:59:09Z","timestamp":1773251949834,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Am Coll Clin Pharm"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Human immunodeficiency virus (HIV) pre\u2010exposure prophylaxis (PrEP) significantly reduces the risk of acquiring HIV. To increase PrEP prescribing, it is crucial to evaluate the preparedness of future pharmacists who will play a pivotal role in providing PrEP education, counseling, and prescribing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We assessed PrEP\u2010prescribing knowledge, attitudes, and HIV\u2010related stigma of pharmacy students.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a cross\u2010sectional web\u2010based survey of student pharmacists in their final two years of education and training at the three University of California pharmacy schools. Survey questions assessed students' awareness of PrEP, familiarity with prescribing guidelines and Senate Bill 159 (SB159), PrEP knowledge, HIV\u2010related stigma, and attitudes about PrEP. The sample was characterized using descriptive statistics, and non\u2010parametric tests were used to examine associations between dependent variables and independent variables. A p\u2010value &lt;0.05 was deemed statistically significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 110 students participated in the survey. The greatest familiarity with guidelines was observed in male (77.4%) (<jats:italic>p<\/jats:italic>\u2009=\u20090.047) and gay\u2010identifying (100%) (<jats:italic>p<\/jats:italic>\u2009=\u20090.039) students compared with other genders and sexual identities, respectively. Non\u2010advanced pharmacy practice experience (APPE) students (70.3%) displayed significantly more familiarity with SB159 than APPE students (65.2%) (<jats:italic>p<\/jats:italic>\u2009=\u20090.006). Non\u2010APPE students displayed higher HIV\u2010related stigma compared with APPE students (13.8 vs. 9.4, <jats:italic>p<\/jats:italic>\u2009=\u20090.0015). Significant differences in PrEP knowledge (<jats:italic>p<\/jats:italic>\u2009=\u20090.0105), HIV\u2010related stigma (<jats:italic>p<\/jats:italic>\u2009=\u20090.0003), and PrEP attitudes (<jats:italic>p<\/jats:italic>\u2009=\u20090.0098) were observed between the schools. African American students had a significantly higher mean PrEP attitudes score (mean\u2009=\u200951.0, standard deviation [SD]\u2009=\u20093.6) compared with other racial categories (<jats:italic>p<\/jats:italic>\u2009=\u20090.0329).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Elevated HIV\u2010related stigma, in the presence of high levels of PrEP knowledge, highlights the need to focus on destigmatizing HIV prevention services and increasing anti\u2010stigma training, which is imperative in preparing student pharmacists to prescribe PrEP.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jac5.2043","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:25Z","timestamp":1730937625000},"page":"1107-1113","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing pharmacy students' <scp>HIV<\/scp> pre\u2010exposure prophylaxis (<scp>PrEP<\/scp>) prescribing knowledge, <scp>PrEP<\/scp> attitudes, and <scp>HIV<\/scp>\u2010related stigma"],"prefix":"10.1002","volume":"7","author":[{"given":"Celeste Noelle","family":"Bustria","sequence":"first","affiliation":[{"name":"San Francisco School of Pharmacy University of California  San Francisco California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finan","family":"Yohannes","sequence":"additional","affiliation":[{"name":"San Francisco School of Pharmacy University of California  San Francisco California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cocohoba","sequence":"additional","affiliation":[{"name":"San Francisco School of Pharmacy University of California  San Francisco California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Irvine Susan &amp; Henry Samueli College of Health Sciences University of California  Irvine California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-549X","authenticated-orcid":false,"given":"Nimish","family":"Patel","sequence":"additional","affiliation":[{"name":"San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences University of California  San Diego California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-5112","authenticated-orcid":false,"given":"Parya","family":"Saberi","sequence":"additional","affiliation":[{"name":"San Francisco School of Pharmacy University of California  San Francisco California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Effective HIV Prevention Strategies | HIV Risk and Prevention Estimates | HIV Risk and Prevention | HIV\/AIDS | CDC.2022[cited 2024 May 2]. Available from:https:\/\/www.cdc.gov\/hiv\/risk\/estimates\/preventionstrategies.html"},{"key":"e_1_2_7_3_1","unstructured":"Expanding PrEP Coverage in the United States to Achieve EHE Goals | 2023 | Dear Colleague Letters | NCHHSTP | CDC.2023[cited 2024 May 2]. Available from:https:\/\/www.cdc.gov\/nchhstp\/dear_colleague\/2023\/dcl-101723-prep-coverage.html"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2019.0189"},{"key":"e_1_2_7_5_1","unstructured":"1747 fe.pdf. [cited2024May6]. Available from:https:\/\/www.pharmacy.ca.gov\/laws_regs\/1747_fe.pdf"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad549"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03494-4"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101334"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2019.01.011"},{"key":"e_1_2_7_10_1","unstructured":"California SB339 | 2023\u20102024 | Regular Session. LegiScan. [cited 2024 May 6]. Available from:https:\/\/legiscan.com\/CA\/text\/SB339\/id\/2832417"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2017.01.025"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-015-1256-y"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-4-13"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/08870446.2011.613995"},{"key":"e_1_2_7_15_1","unstructured":"Understanding HIV where you live. Available at:https:\/\/aidsvu.org\/(Accessed September 12 2024) n.d."},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cptl.2023.02.019"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101590"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.3386\/w26345"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.1930"},{"key":"e_1_2_7_20_1","unstructured":"Ending the HIV epidemic in the US (EHE) (no date) Ending the HIV Epidemic in the US (EHE). Available at:https:\/\/www.cdc.gov\/ehe\/index.html(Accessed September 12 2024) n.d."}],"container-title":["JACCP:  JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jac5.2043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:14:34Z","timestamp":1760530474000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jac5.2043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1002\/jac5.2043"],"URL":"https:\/\/doi.org\/10.1002\/jac5.2043","archive":["Portico"],"relation":{},"ISSN":["2574-9870","2574-9870"],"issn-type":[{"value":"2574-9870","type":"print"},{"value":"2574-9870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}